Are we improving the outcome for patients with T-cell prolymphocytic leukemia by allogeneic stem cell transplantation?

Eur J Haematol. 2015 Mar;94(3):191-2. doi: 10.1111/ejh.12462.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols*
  • Clinical Trials as Topic
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, Prolymphocytic, T-Cell / drug therapy*
  • Leukemia, Prolymphocytic, T-Cell / mortality
  • Leukemia, Prolymphocytic, T-Cell / pathology
  • Survival Analysis
  • Transplantation, Autologous
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Alemtuzumab